TODD STRATEGY GROUP

Lobbying for KALEO · Pharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · $40,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Pharmacy

Prescription drug pricing. Medical countermeasure development and procurement.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem